Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.
about
Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.Clinical implications of recent advances in proteogenomics.Proteogenomics for understanding oncology: recent advances and future prospects.Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.PITDB: a database of translated genomic elements.Progranulin and its biological effects in cancer.The aurum sample
P2860
Q38660073-BA98DC51-B86C-4E03-B39A-7E0B116C1D03Q38665267-1BC6C6FE-290E-4FFF-9FC3-6248034285BCQ38677257-49023A5E-D6F5-4ABE-8366-A794AB1C2A57Q38918710-557E9DF7-8037-4DF5-840E-0DFAF9549B59Q47122790-C4397ED6-0798-4E9E-A69F-8356B6026928Q47425664-6F972B24-9BE2-432C-83AC-9DDF66A5FD00Q57528817-658D6F59-7345-4E48-8F10-459F02F1CE88
P2860
Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@ast
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@en
type
label
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@ast
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@en
prefLabel
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@ast
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Onco-proteogenomics identifies ...... s of hepatocellular carcinoma.
@en
P2093
Chao-Jen Kuo
Chi-Chao Chen
Chun-Hao Huang
Edward Hsi
King-Teh Lee
Shu-Wen Chi
Shyh-Horng Chiou
P2860
P304
P356
10.1016/J.BBACLI.2015.02.004
P577
2015-03-03T00:00:00Z